Get ready to turn heads, because AmLactin and Kerasal, are flipping the script with their #UnsexyDesignChallenge! These powerhouse, albeit underrated, brands are embracing their "unsexy" status and ...
If you have rough, bumpy skin on your arms, legs or face, these treatments and creams will smooth your skin for summer — read ...
Analysis of the primary and secondary endpoints of the phase 2/3 ACTISAVE study showed no improved efficacy with glenzocimabKey results from this study will be ...
Analysis of the primary and secondary endpoints of the phase 2/3 ACTISAVE study showed no improved efficacy with glenzocimab Key results from this study will be presented at ESOC on May 15, 2024 ...
ACTICOR BIOTECH (FR0014005OJ5 - ALACT) (Paris:ALACT), a clinical-stage biotechnology company focused on the development of glenzocimab, an innovative drug for the treatment of cardiovascular ...
The Ioniq 5 N is Hyundai's first all-electric performance car, but it won't be the last. And the automaker is even looking at a hydrogen N model. The Hyundai Ioniq 5 N, based on the automaker’s ...
First Period_1, Carolina, Kuznetsov 1 (Necas, Skjei), 1:35 (pp). 2, N.Y. Islanders, MacLean 1 (Lee, Romanov), 8:20. Second Period_None. Third Period_3, Carolina ...
PARIS--(BUSINESS WIRE)--Regulatory News: ACTICOR BIOTECH (ISIN: FR0014005OJ5 “ ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback